| Clinical
Research Information For Sponsors
Founded in 1987, the Chicago Institute of Neurosurgery
and Neuroresearch (CINN) has emerged as one of the
nation's leading institutions for the diagnosis, treatment
and rehabilitation of patients with nervous system
conditions. CINN treats more patients with brain tumors
and spine disorders than any other institution in
Illinois. Currently, we have 7 centers servicing
more than 20,000
patients annually, and our Network represents one
of the largest and busiest neuroscience practices
in the country.
CINN comprises one of the nation's largest, most proficient
groups of neurosurgeons, whose members represent every
subspecialty in the field. Also included in the CINN
network are physicians in related fields such as neurology,
physiatry and internal medicine. More patients choose
CINN for the surgical care than any other institution
in the Chicago area.
Since 1995, CINN has been committed to recruiting,
managing and executing clinical research protocols to
the hishest standards for the pharmaceutical and medical
device industries. Our objective is to constantly strive
for flawless execution of protocols. We have a highly
dedicated and experienced clinical research staff and
can accommodate Phase I through Phase IV class protocols.
We are also experienced in the design and management
of comprehensive, longitudinal quality of life studies
relating to clinical outcomes.
CINN has the clinical expertise and patient population
to conduct research in:
|
Alzheimer's
Disease |
 |
Pain Management
|
 |
Brain tumors,
primary and metastatic |
 |
Parkinson's
Disease |
 |
Carpal Tunnel
Syndrome |
 |
Peripheral Neuropathy |
 |
Devices |
 |
Seizure Disorders |
 |
Epilepsy |
 |
Spine Disorders including Degenerative Disc Disease,
Osteoarthritis, Trauma, Congenital Malformations,
Tumor and Vascular Abnormalities |
 |
Headache |
 |
Migraine Headaches |
 |
Movement Disorders
|
 |
Stroke |
 |
Musculoskelatal
Diseases |
 |
Vascular Disorders,
including aneurysms and AVMs |
CINN has conducted studies with the following companies:
 |
Archus
Orthopedics, Inc. |
 |
Link Spine Group,
Inc. |
 |
Bertlex Laboratories,
Inc. |
 |
Medtronic, Inc. |
 |
Boston Scientific
Corporation |
 |
NeoPharm, Inc. |
 |
Ceregene, Inc. |
 |
NeuroPace, Inc. |
 |
Codman & Shurtleff,
Inc |
 |
Northstar Neuroscience,
Inc. |
 |
Confluent Surgical,
Inc. |
 |
Novartis Pharmaceuticals |
 |
Cortek, Inc. |
 |
Ortho Biotech
Inc. |
 |
DePuy AcroMed
Corporation |
 |
Osteotech Inc. |
 |
Fidia Pharmaceutical |
 |
Seacoast Therapeutics,
Inc. |
 |
Genzyme Biomatrix,
Inc. |
 |
Sofamor Danek
Inc. |
 |
Gliatech Inc. |
 |
Stereotaxis,
Inc. |
 |
Guilford Pharmaceuticals |
 |
Sulzer-Spine
Tech Inc. |
 |
Integra LifeSciences
Corporation |
 |
Synthes Spine |
 |
Interpore Cross
International |
 |
U.S. Surgical
Dynamics, Inc. |
 |
Johnson & Johnson
Professionals |
 |
|
Work for contract research organizations has included:
 |
Berger-Boyer
& Associates |
 |
PAREXEL International
Corp. |
 |
Boston Biostatistics,
Inc. |
 |
PPD Development |
 |
INC Research |
 |
Quintiles, Inc. |
 |
J. Tyson &
Associates, Inc. |
 |
Statprobe, Inc. |
 |
Medical Device
Consultants, Inc. |
 |
Sulzer-Spine
Tech Inc. |
For further information
A list of current trials.
For more information, please contact
Vice President of Endovascular Services and Research.
She can also be reached by mail at CINN, 4501 North
Winchester Avenue, 3rd Floor, Chicago, Illinois, 60640
or by phone at 773/250-0500.
|